Helminthic therapy and cancer
There are many different helminth species belonging to different phyla. Since these may use different mechanisms from each other, the effects of one species can not be generalized to others.
Some helminths cause cancer, while others protect against it[edit | edit source]
Helminths that have been identified as being carcinogenic include the fish-borne trematodes Opisthorchis viverrini and Clonorchis sinensis and the blood fluke Schistosoma haematobium, all of which are categorised by the International Agency for Research on Cancer as Group 1 biological carcinogens. [3] [4]
The helminths used for therapeutic purposes (NA, TT, TS and HD) are not carcinogenic (see Helminthic therapy safety), but one helminthic therapist has suggested that, since some solid mass tumours like to surround themselves with regulatory immune cells, it may be unwise to increase this cell population in patients with a history of solid mass tumours. [5]
See also
- 2025 Jan 8 Reinventing type 2 immunity in cancer (Nature)
Cancer-promoting helminths[edit | edit source]
Three helminth infections have been classified as definitely carcinogenic to humans (group 1 carcinogens), namely Schistosoma haematobium, which is associated with cancer of the urinary bladder and the food-borne liver flukes Clonorchis sinensis and Opisthorchis viverrini associated with cholangiocarcinoma of the liver
- 2025 Dec Can flukes cause cancer? Insight into molecular links between parasites and carcinogenesis
- 2025 Oct 2 The immune microenvironment of pathogen-associated cancers and current clinical therapeutics
- 2025 Aug 29 Carcinogenic parasites: insights into the epidemiology and possible mechanisms of cancer
- 2024 Mar 20 Convergence between helminths and breast cancer: intratumoral injection of the excretory/secretory antigens of the human parasite Toxocara canis (EST) increase lung macro and micro metastasis -- Full text | PDF
- 2024 Mar The Parasitism and Tumors Carcinogenesis: A Review Subject
- 2023 Dec 14 From the discovery of helminths to the discovery of their carcinogenic potential -- Full text
- 2023 Oct 30 A novel proteomic-based model for predicting colorectal cancer with Schistosoma japonicum co-infection by integrated bioinformatics analysis and machine learning
- 2023 Jul 26 Cancerogenic parasites in veterinary medicine: a narrative literature review -- Full text | PDF
- 2022 Dec Spotlights on helminth pathogens’ innovative pathways of tumorigenesis
- 2022 Jul 25 Roles of microRNAs and Long Non-Coding RNAs Encoded by Parasitic Helminths in Human Carcinogenesis -- Full text | PDF
- 2021 Aug 4 Does Schistosoma Mansoni Facilitate Carcinogenesis?
- 2021 Mar 24 Control Strategies for Carcinogenic-Associated Helminthiases: An Integrated Overview
- 2021 Feb Echinococcus granulosus protoscoleces promotes proliferation and invasion of hepatocellular carcinoma cells
- 2021 Jan 26 Spirocerca lupi Proteomics and Its Role in Cancer Development: An Overview of Spirocercosis-Induced Sarcomas and Revision of Helminth-Induced Carcinomas
- 2020 Aug 21 Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE)
- 2020 May 29 Potential Novel Risk Factor for Breast Cancer: Toxocara canis Infection Increases Tumor Size Due to Modulation of the Tumor Immune Microenvironment -- Full text | PDF
- 2018 Mar 29 Pearls collections: What we can learn about infectious disease and cancer
- 2019 Dec 6 Neglected Agent Eminent Disease: Linking Human Helminthic Infection, Inflammation, and Malignancy -- Full text | PDF
- 2017 Jul Helminth infection-induced malignancy
- 2017 Parasite-Associated Cancers (Blood Flukes/Liver Flukes)
- 2016 Jun 15 Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: A systematic review
- 2015 Nov 1 Why does infection with some helminths cause cancer? -- Full text | PDF
- 2015 Helminth Infections Mediated DNA Damage: Mechanisms and Consequences
- 2014 Jul Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer -- Full text | PDF
- 2011 Jun 28 Helminths in human carcinogenesis
- 2009 Nov Helminths and malignancy -- Full text
- 2007 The role of helminth infections in carcinogenesis
- 2005 Apr Association of parasitic infections and cancers
- 1980 Jun Helminths in the induction of cancer: Opisthorchis viverrini, Clonorchis sinensis and cholangiocarcinoma
The protective role of helminths[edit | edit source]
Helminths may be able to elicit anti-tumor immune responses that can lead to protection from tumorigenesis, or even to cancer regression.
Helminth infection may limit the growth and dispersion of tumors.
Helminths reduce the level of IGF-1, which promotes the growth of certain tumors.
- 2020 Nov 4 Effect of anthelmintic treatment on serum free IGF-1 and IGFBP-3: a cluster-randomized-controlled trial in Indonesia -- Full text | PDF.
See also (may not be related)
- 2025 Jan 8 Reinventing type 2 immunity in cancer (Nature)
- 2023 Nov 1 Dopamine Receptor 1 Impedes ILC2-Mediated Antitumor Immunity
- 2022 Sep Eosinophil–lymphocyte interactions in the tumor microenvironment and cancer immunotherapy -- Full text | PDF
- 1998 Dec 21 The central role of CD4(+) T cells in the antitumor immune response
Effect of helminths by type of cancer[edit | edit source]
Adenosarcoma[edit | edit source]
See also
Sarcoma-180 ascites tumors[edit | edit source]
- 1979 Dec Influence of Trichinella spiralis infection on development of sarcoma-180 ascites tumors
- 1975 Sep Quantitative study of the effect of previous Trichinella spiralis infection on sarcoma 180 ascitic tumor formation in mice
Bladder cancer[edit | edit source]
Schistosoma haematobium is known to promote cancer
Breast cancer[edit | edit source]
- 2025 Sep 8 [https://helminthconference.org/wp-content/uploads/2025/10/Hydra-Helminth-Conference-Full-Programme-2025.pdf Anti-tumoral effect of Echinococcus granulosus hydatid fluid in a cell-derived breast cancer xenograft model)
- 2025 Apr 17 Unveiling the anti-neoplastic potential of Schistosoma mansoni-derived antigen against breast cancer: a pre-clinical study
- 2024 Mar 12 MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid
- 2024 Feb 3 Deciphering the Dual Role of Heligmosomoides polygyrus Antigens in Macrophage Modulation and Breast Cancer Cell Growth -- Full text
- 2022 Apr-Jun Anticancer Activity of Hydatid Cyst Fluid along with Antigen B on Tumors Induced by 4T1 Breast Cancer Cell in a BALB/c Mice Model
- 2021 Oct Anti-cancer immunoprotective effects of immunization with hydatid cyst wall antigens in a non-immunogenic and metastatic triple-negative murine mammary carcinoma model
- 2021 Feb 12 Hymenolepis diminuta-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progression -- Full text | PDF.
- 2020 Dec 11 Immunization with Hydatid Cyst Wall Antigens Can Inhibit Breast Cancer through Changes in Serum Levels of Th1/Th2 Cytokines
- 2020 Jan In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells
- 2018 Aug 31 Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer
- 2019 Aug 12 Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice
- 2019 Apr 10 Effect of Hydatid Cyst Fluid Antigens on Induction of Apoptosis on Breast Cancer Cells
- 2015 Jan Co-existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses (Comments : 2015 Aug Immune system in cancer and hydatid disease: cross-reactivity vs. immune modulation and 2015 Aug Echinococcus and cancer: unsolved mystery
See also:
- 2016 Apr 1 Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis -- Full text
- 2011 Apr 13 IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells -- Full text | PDF
- 2008 Oct NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells
- 1994 Dec 15 An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4
- 1993 Apr 1 Ultrastructural evidence of the mechanisms responsible for interleukin-4-activated rejection of a spontaneous murine adenocarcinoma
Colorectal cancer[edit | edit source]
According to a review [6], Necator americanus could, in theory, reduce risk of colorectal cancer by several means:
- acting on obesity (leptin), diabetes (IGF-I levels), IBD (2–6 times higher CRC risk due to complex carcinogenic mechanisms), dysbiosis (alterations in gut microbiota composition also contribute to CRC risk, the dysbiosis promotes the transition from adenoma to invasive cancer), butyrate level (the loss of butyrate-producing bacteria in obesity and type 2 diabetes further promotes inflammation and tumorigenesis)
- acting on inflammation which causes oxidative stress and DNA damage, triggering a sequence from inflammation to dysplasia to cancer
- acting on NF-κB signaling and triggers inflammatory processes, which contribute to carcinogenesis
- downregulate TNF-α, IL-17
According to another study [7], "IL-25 plays an inhibitory role in the growth and development of colonic tumors".
Here is a testimonial :
- "Originally my doctor wanted to try these guys (NA) as an experiment to see if they help with reducing my cancer. We also found out these guys help the genetic condition that caused my cancer (FAP) which mimics an autoimmune disease. There are few studies that prove that elevated eosinophils actually help kill colorectal cancer cells. Six months into it, I'm cancer free." [8]
Scientific papers :
- 2025 Sep 20 The Impact of Helminths on Colorectal Cancer: From Infections to the Isolation of Biotherapeutics -- Full text | PDF
- 2025 Sep 11 Helminth-induced alterations of CD8+ T cell immunity and its impact on colorectal cancer (Conference)
- 2025 Sep 8 Gut virome remodeling in HIV–helminth co-infection reflects colorectal cancer–associated signatures in a South African cohort also Virome restructuring in HIV-helminth co-infection reveals potential biomarkers for colorectal cancer in a South African cohort
- 2025 Aug 13 Global prevalence and correlation of intestinal parasitic infections in patients with colorectal cancer: a systematic review and meta-analysis -- Full text
- 2025 Sep 8 Selective packaging of anti-fibrotic and tumour suppressor miRNAs in extracellular vesicles of a parasitic whipworm (Conference)
- 2025 Jul Helminth-induced prostaglandin signaling and dietary shifts in PUFA metabolism promote colitis-associated cancer -- Full text | PDF
- 2025 Apr 14 Helminth-induced immune modulation in colorectal cancer: exploring therapeutic applications -- Full text | PDF
- 2025 Feb 24 Natural Alternatives in the Treatment of Colorectal Cancer: A Mechanisms Perspective -- PDF download
- 2025 Jan 9 Immunotherapy in gastrointestinal cancers: current strategies and future directions - a literature review -- Full text | PDF
- 2025 Jan Defining a mechanism for Heligmosomoides polygyrus bakeri exacerbation of colorectal cancer development -- PDF (Thesis)
- 2022 Jun 3 An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis -- Full text | PDF
- 2021 Apr 29 Immune Protection of a Helminth Protein in the DSS-Induced Colitis Model in Mice -- Full text | PDF
- 2021 Feb 1 Type 2 Innate Lymphoid Cells Protect against Colorectal Cancer Progression and Predict Improved Patient Survival -- Full text | PDF
- 2020 Dec 21 The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses
- 2020 Oct 22 Gastrointestinal Nematode-Derived Antigens Alter Colorectal Cancer Cell Proliferation and Migration through Regulation of Cell Cycle and Epithelial-Mesenchymal Transition Proteins -- Full text | PDF
- 2018 Aug Cancer cell behaviour following parasite exposure -- PDF (Master thesis)
Surprisingly, while antigen from H. polygyrus inhibited human colorectal cancer cell migration, it had the opposite effect on mouse colorectal cancer cells, suggesting that its impact on colorectal cancer migration may be, at the very least, species dependent.
- 2017 Sep 22 Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer -- Full text
- 2016 May 11 Acute blockade of IL-25 in a colitis associated colon cancer model leads to increased tumor burden -- Full text | PDF
- 2014 Aug 24 Extraintestinal helminth infection reduces the development of colitis-associated tumorigenesis -- Full text
- 2011 Nov 30 Gastrointestinal neoplasia associated with bowel parasitosis: real or imaginary? -- Full text | PDF
Cancer promotion
See also (may not be directly related)
- 2025 Jul 11 The role of gut microbiome in colorectal cancer development: a comprehensive analysis based on metabolomics and immunomodulatory mechanisms -- Full text | PDF
- 2019 Oct 17 Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis -- Full text | PDF
- 2020 Oct 3 Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
- 2016 Mar 1 Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth
- 2010 Dec 15 Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells
Fibrosarcoma[edit | edit source]
See also
- 2007 Apr 1 Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance
- 1990 Nov 1 Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory
Gastric cancer[edit | edit source]
- 2022 Dec 9 The impact of Helicobacter pylori and intestinal helminth infections on gastric adenocarcinoma and inflammatory bowel disease in Sub-Saharan Africa -- Full text | PDF
- The high prevalence of helminth infections in Sub-Saharan Africa may be responsible for a reduced risk of gastric adenocarcinoma.
- 2014 Apr Helminth co-infection in Helicobacter pylori infected INS-GAS mice attenuates gastric premalignant lesions of epithelial dysplasia and glandular atrophy and preserves colonization resistance of the stomach to lower bowel microbiota -- Full text | PDF
- 2014 Mar 4 Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer -- Full text | PDF (May not be related)
- 2005 Jun Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis -- Full text
- Helminth infection may alter inflammatory responses to H. pylori and thus affect the progression of gastritis to gastric atrophy, dysplasia, and cancer.
- 2000 Apr Intestinal helminth infection modulates inflammation and reduces gastric atrophy in a mouse model of Helicobacter infection -- PDF
See more here:
Leukemia, myeloma and lymphoma[edit | edit source]
- 2024 Dec 31 The Impact of Cell-Intrinsic STAT6 Protein on Donor T Cell-Mediated Graft-Versus-Tumor Effect -- Full text | PDF
- 2023 Dec 1 Impact of pinworm infection on the development of murine B-cell leukemia/lymphoma in the presence and absence of ETV6::RUNX1 -- Full text | PDF (editorial Worms on stage)
- 2023 Jun 9 After Bone Marrow Transplantation, the Cell-Intrinsic Th2 Pathway Promotes Recipient T Lymphocyte Survival and Regulates Graft-versus-Host Disease -- Full text | PDF
- 2020 Sep 22 Intestinal Nematode Infection Affects Metastasis of EL4 Lymphoma Cells -- Full text | PDF
- 2020 Jul 10 Polarization of human acute monocytic leukemia THP-1 cells-derived macprophages induced by Nippostrongylus brasiliensis proteins in vitro (Chinese)
- 2019 Mar Intestinal Immune Conditioning with Helminths Employs Host T Helper 2 (Th2) Pathway to Induce Mixed Chimerism and Regulate Graft-Versus-Host Disease -- PDF
- 2018 Oct 5 Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells -- Full text | PDF
- 2015 Feb 1 Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versustumor effect in mice -- Full text | PDF (Helminths improve the outcome of bone marrow transplantation in mice)
See also
- Helminthic therapy and graft-versus-host disease (GVHD)
- Helminthic therapy and infectious diseases: Human T-cell Leukemia Virus Type 1 (HTLV-1)
See also (not directly related)
- 2022 Jan 8 Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia -- Full text | PDF (helminths boost IL-10)
- 2021 Aug 27 Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage -- Full text | PDF
- 2018 Aug A causal mechanism for childhood acute lymphoblastic leukaemia -- Full text | PDF
- 2016 Mar 1 Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth
- 2011 Aug Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia -- Full text | PDF (helminths boost IL-10)
T-cell large granular lymphocyte leukemia[edit | edit source]
There are no known studies or testimonials regarding the effects of helminths on T-cell LGL lymphocytic leukemia.
Several clues suggest that helminthic therapy is potentially an avenue worth exploring:
Diseases involving T lymphocytes. graft-versus-host disease (GVHD), organ transplantation, autoimmune diseases
Immunosuppressive treatments. Helminthic therapy works on diseases that use immunosuppressive treatments such as Methotrexate.
Vitamin D Helminth therapy acts on similar pathways and conditions.
- 2017 May 4 Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia
- 2018 Mar Calcitriol-mediated reduction in IFN-γ output in T cell large granular lymphocytic leukemia requires vitamin D receptor upregulation
Associated autoimmune diseases "LGL leukemia is frequently associated with autoimmune disorders such as rheumatoid arthritis, Sjögren's syndrome, autoimmune endocrinopathies, vasculitis, or autoimmune cytopenia"[9]
- 2024 Jan 18 The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders
- 2022 Jun 7 Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease
- 2022 Mar 5 Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness
- 2021 Jun 15 The non-leukemic T cell large granular lymphocytic leukemia variant with marked splenomegaly and neutropenia in the setting of rheumatoid arthritis - Felty syndrome and hepatosplenic T cell lymphoma mask.
Up to 28% of patients with T-LGL leukemia have rheumatoid arthritis (RA):
Pro-inflammatory cytokines Helminths shift immunity from Th1/Th17 inflammatory cytokines to Th2 immunity.
- 2024 Jan 1 Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia
- 2023 Oct 12 Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia
- 2022 Mar 10 Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia
- 2019 May IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability
- 2018 Feb 23 Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia
NF-κB pathway Helminths downregulate the NF-κB pathway.
- 2018 Jun 21 TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia
- 2008 Oct 21 Network model of survival signaling in large granular lymphocyte leukemia
See also
- 2026 Jan 20 Selective Immune Silencing by Targeted TGF-β Agonists (Preprint)
Here, we exploit the immunosuppressive properties of Transforming growth factor beta (TGF-β), through selective “silencing” of T and B cells by a targeted TGF-β mimic agonist derived from Helminths.
- 2025 Apr Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity
- 2024 Dec 6 Large granular lymphocyte leukemia: a clonal disorder with autoimmune manifestations
LGL leukemia is frequently associated with autoimmune disorders such as rheumatoid arthritis, Sjögren's syndrome, autoimmune endocrinopathies, vasculitis, or autoimmune cytopenia:
- 2024 Oct 31 A modern view of LGL leukemia
- 2024 Mar 27 Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment
- 2023 Jun Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders
- 2023 Apr 30 T-large granular lymphocytic leukemia
- 2022 Feb 10 T-Cell Large Granular Lymphocyte Leukemia: An Interdisciplinary Issue?
To determine whether helminths are relevant to this disease please see Medical conditions and their response to helminthic therapy: Steps to take for a specific condition
Liver Cancer (Hepatocellular Carcinoma)[edit | edit source]
- 2025 Sep Functionalized Trichinella spiralis anti-tumor protein with polydopamine for hepatocellular carcinoma phototherapy and immunotherapy
- 2024 Sep 4 Schistosoma japonicumsja-let-7 Inhibits the Growth of Hepatocellular Carcinoma Cells via Cross-Species Regulation of Col1α2 -- Full text | PDF
- 2024 Mar Assessing the Potential Apoptotic Effects of Different Hydatid Cyst Fluids on Human Healthy Hepatocytes and Hepatocellular Carcinoma Cells
- 2022 Sep Exploring the role of macrophages in determining the pathogenesis of liver fluke infection -- Full text | PDF
- 2022 Apr 26 Peptide of Trichinella spiralis Infective Larval Extract That Harnesses Growth of Human Hepatoma Cells -- Full text | PDF
- 2022 Jan Excretory-secretory product of Trichinella spiralis inhibits tumor cell growth by regulating the immune response and inducing apoptosis
- 2021 Mar 1 The Apoptotic Effect of Trichinella spiralis Infection Against Experimentally Induced Hepatocellular Carcinoma -- Full text | PDF
- 2020 Jul 21 Murine hepatoma treatment with mature dendritic cells stimulated by Trichinella spiralis excretory/secretory product
See also
- 2026 Feb Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications
- 2025 Dec 8 Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma -- Full text | PDF
- 2025 Dec 1 Regulatory Role and Biomarker Potential of Gut Microbiota Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease to Hepatocellular Carcinoma -- Full text | PDF
- 2025 Dec Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification -- Full text | PDF
- 2025 Sep 3 Immunotherapy resistance in MASLD-related hepatocellular carcinoma: special immune microenvironment and gut microbiota -- Full text | PDF
- 2025 Sep Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma
- 2025 Jun 18 Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis -- Full text | PDF (in correlation with 2024 May Regulation of host metabolic health by parasitic helminths -- PDF)
- 2025 Jun Regulatory role of gut microbiota in immunotherapy of hepatocellular carcinoma
- 2025 May Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation -- Full text | PDF
- 2025 Feb 25 Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma -- Full text | PDF
- 2015 Sep Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
- 2004 Sep Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma
See also
- Helminthic therapy and cardiometabolic conditions / Non-alcoholic fatty liver disease
- Helminthic therapy and the liver
- Helminthic therapy and infectious diseases / Helminths and hepatitis virus
Lung Cancer[edit | edit source]
- 2023 Jul 31 Transcriptome profiling of A549 non-small cell lung cancer cells in response to Trichinella spiralis muscle larvae excretory/secretory products -- Full text | PDF
- 2021 Apr Evaluation of the Effect of Hydatid Cyst Fluid on the Apoptosis Pathway in BEAS-2B and A549 Cell Lines (Turkish)
- 2020 Sep 22 Intestinal Nematode Infection Affects Metastasis of EL4 Lymphoma Cells -- Full text | PDF
- 2017 May Study on the mitochondrial apoptosis pathways of small cell lung cancer H446 cells induced by Trichinella spiralis muscle larvae ESPs -- Full text
Cancer promotion
- 2014 Aug Effect of the excretory/secretory proteins from Trichinella spiralis on apoptosis of NCI-H446 small-cell lung cancer cells (Chinese)
Melanoma[edit | edit source]
- 2024 Mar 20 Suppression of the growth and metastasis of mouse melanoma by Taenia crassiceps and Mesocestoides corti tapeworms
- 2021 Apr MicroRNA-365 promotes apoptosis in human melanoma cell A375 treated with hydatid cyst fluid of Echinococcus granulosus sensu stricto
- 2019 Nov 7 Kunitz type protease inhibitor from the canine tapeworm as a potential therapeutic for melanoma
- 2018 Sep 30 Effect of hydatid cyst antigens on inhibition of melanoma cancer growth in mouse model
- 2016 Dec Effect of two hydatid cyst antigens on the growth of melanoma cancer in C57/black mice
- 2015 Apr 22 Necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction
- 2013 Sep 1 Trichinella spiralis infection reduces tumor growth and metastasis of B16-F10 melanoma cells
Cancer promotion
See also (This may not be directly related) :
- 2024 May 28 LKB1 prevents ILC2 exhaustion to enhance antitumor immunity -- Full text
- 2021 Oct 8 Innate Lymphoid Cells in Skin Homeostasis and Malignancy -- Full text | PDF
- 2021 Aug 31 PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma -- Full text | PDF
- 2021 Jul Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
- 2021 Jun 24 Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity
- 2020 Feb 25 Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s -- Full text
- 2017 Apr 20 IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
- 2016 Mar 1 Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth
- 2012 Oct 16 Loss of cutaneous TSLP-dependent immune responses skews the balance of inflammation from tumor protective to tumor promoting -- Full text
- 2012 Oct 16 Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin -- Full text | PDF
- 2003 Feb 3 Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process
Ovarian Cancer[edit | edit source]
See also
Pancreatic cancer[edit | edit source]
- 2023 Apr 1 Can Echinococcus Granulosus Infestation Prevent Pancreatic Cancer? An invivo Experimental Study
- 2020 Oct 29 Historical analysis of inverse correlation between soil-transmitted helminthiasis and pancreatic cancer -- Full text | PDF
It is posited that a high rate of infection by soil-transmitted helminth in developing countries and rural areas protects the human host from the development of pancreatic cancer, possibly by immune modulation
See also (not directly related)
- 2022 Feb 22 Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
Osteosarcoma[edit | edit source]
Papillomavirus induced cervical cancer[edit | edit source]
- 2025 Aug 5 Understanding the association between immune modulating helminths and human papillomavirus or cervical cancer: a scoping review (preprint)
- 2024 Jan Regulation of HPV infection and cervical cancer development following a helminth infection -- PDF (Thesis)
Together, these findings show that helminth infection can protect against distal viral infection and suppress the growth and cancer cell behaviour of HPV associated cervical cancer
- 2018 Aug 1 Hookworm exposure decreases human papillomavirus uptake and cervical cancer cell migration through systemic regulation of epithelial-mesenchymal transition marker expression -- Full text | PDF
- 2018 Aug Cancer cell behaviour following parasite exposure -- PDF (Master thesis)
For more publications see Helminthic therapy and infectious disease, papillomavirus
HIV-Helminth co-infections and cancer risk[edit | edit source]
- 2025 Mar 20 HIV-Helminth Co-Infections and Immune Checkpoints: Implications for Cancer Risk in South Africa -- Full text | PDF
See also Helminths and HIV
Necator americanus and IFN-γ[edit | edit source]
- To be read in conjunction with:
Cancer has been linked to inflammation, which is controlled by helminths[edit | edit source]
Helminths and their products may potentially treat cancer[edit | edit source]
The scientific literature reveals that various cancer types have shown promising responses to parasite therapy in both in vitro and in vivo animal studies.
Helminths exert antitumor effects via several mechanisms of action.
The following anecdotal report suggests a positive contribution by NA to treatment in one case of cancer.
- And an update three years later.
Re-innoculated myself with 10 N. americanus (NA) on July 13th 2023, after successfully hosting NA back in late 2019 and into 2022. My goal back in 2019 and now remains the same. Combatting my hereditary condition known as FAP (familial adenomatous polyposis) which fueled my diagnosis of Stage IV colorectal cancer five years ago, at the age of 30. Within the first 3-4 months; my body, spirit, overall health - and cancer prognosis - sobered up! I was also put on (just before inoculation) a last ditch effort immunotherapy that had "little hope of prolonged life". This PD-1 inhibitor treatments, in my opinion, might have worked synergistically with the NA response to my immuno profile. I credited the NA on two things; 1) helping my body repair DNA and address inflammation from my flawed inherited genes, & 2) promote pathways that helped go after my tumors littered throughout my lymph nodes, liver, diaphragm, and colon. Specifically interleukin pathways and the release of high amounts of eosinophils (EOs) which are known to interrupt colorectal cancer cells. This also helped me during my first reoccurrence with the disease in early 2021, while on an experimental trial in which I was about the best (of very few) positive responses. I killed off my previous colony in favor of a highly recommended protocol involving a common ingredient in dog dewormer while in remission in October of 2022, my last NA innoculation before killing off the NA was in April 2022. Fast forward to now (2023) I was recently re-diagnosed with cancer after another year of remission. My last CT scan showed some growth in my lymph nodes with no additional spread. Hoping this works with my last standard of care treatment. [12]
Worm-derived molecules could be potential candidates for anti-cancer drugs[edit | edit source]
- 2024 Sept 17 Anisakis extracellular vesicles elicit immunomodulatory and potentially tumorigenic outcomes on human intestinal organoids -- Full text | PDF
- 2023 Jun Anti-Tumor Effect of Protoscolex Hydatid Cyst Somatic Antigen on Inhibition Cell Growth of K562
- 2022 Jan-Mar Anti-Tumor Effect of Marshallagia marshalli Somatic Antigen on Inhibition Cell Growth of K562 -- Full text | PDF
- 2016 Jan 29 Common antigens between hydatid cyst and cancers
Helminths and CAR-T cells therapy[edit | edit source]
Chemotherapy-induced pathologies[edit | edit source]
Helminths act on side effects of chemotherapy: leaky gut, blood-brain barrier permeability, chronic inflammation, neuroinflammation and brain fog.
See also
- 2025 Dec 5 Gut microbiome and chemotherapy-induced cardiotoxicity: A systematic review of evidence and emerging therapies -- Full text | PDF
- 2025 Jan 28 Chemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics: A Systematic Review
Molecular mimicry between parasites and cancer[edit | edit source]
- 2025 May 22 Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies -- Full text | PDF
- 2018 Apr 18 Similarities and differences between helminth parasites and cancer cell lines in shaping human monocytes: Insights into parallel mechanisms of immune evasion -- Full text | PDF
Infection with other microorganisms may also help to reduce cancer risk[edit | edit source]
BCG vaccination in infancy confers a survival advantage for melanoma patients, and vaccination of adults against yellow fever may have a similar effect.
Infection with the feline parasite, Toxoplasma gondii, stimulates the body to produce natural killer cells and cytotoxic T cells, which wage war on cancer cells.
Rather than the presence of infectious microorganisms increasing cancer risk, a lack of them may be the greater problem.
See also
- 2025 Jul 29 Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions -- Full text | PDF
Microbiota and Cancer[edit | edit source]
- 2026 Jan Microbiota and cancer immunotherapy: Mechanisms, clinical implications, and precision therapeutics
- 2025 Dec The role of microbiome in immunotherapy: Insights and perspectives
- 2025 Dec Microbiota metabolism and immune regulation: From mechanisms to immunotherapeutic applications in cancer
- 2025 Nov 21 Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy -- Full text | PDF
- 2025 Oct 17 Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives -- Full text | PDF
- 2025 Oct The microbiota-gut-brain-axis theory: role of gut microbiota modulators (GMMs) in gastrointestinal, neurological, and mental health disorders -- Full text | PDF
- 2025 Aug 8 Microbiota-derived metabolites: Key modulators of cancer immunotherapies -- Full text
- 2025 May 25 The Microbiome Connection: A Common Pathway Linking Cancer and Heart Failure -- Full text | PDF
- 2024 Dec 23 Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease -- Full text | PDF
- 2020 Mar 4 Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer -- Full text | PDF
Anthelmintic drugs may be used in cancer treatment[edit | edit source]
This does not mean that terminating any helminths that a cancer patient may be hosting will help to treat their cancer.
When an anthelmintic drug such as mebendazole (Vermox) is used in cancer treatment, it is not because of its worm-killing effects, but because of its ability to act directly on cancers, blocking tumor growth and spread, inducing apoptosis, and increasing sensitivity to other anti-cancer therapies. [15]
However, the use of an anthelmintic as part of a patient’s cancer treatment would prevent that patient from hosting helminths while they remain on that treatment.
When a helminth, itself, gets cancer[edit | edit source]
This rare case in which a man died after a tapeworm inside him developed cancer, involved a helminth that is not used in therapy.
For a discussion about this case, see this support group thread.
Reviews and meta-analysis[edit | edit source]
- 2026 Jan 13 Cancer in disguise: a parasite within
- 2025 Jul 29 Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions -- Full text | PDF
- ✅ 2025 Jan 8 Reinventing type 2 immunity in cancer (Nature)
- 2024 Oct 9 The role of helminths and their antigens in cancer therapy: insights from cell line models -- Full text | PDF
- 2024 Oct 5 Parasites revive hope for cancer therapy -- Full text | PDF
- 2024 Aug 9 Antitumor Effect Induced by Protozoa and Helminth Infections: Current Trends and Future Perspectives (book chapter of Pathogens Associated with the Development of Cancer in Humans)
- 2024 Jul 29 Mining parasites for their potential as novel therapeutic agents against cancer -- Full text
- 2024 Mar 29 How tapeworms interact with cancers: a mini-review -- Full text | PDF
- 2023 Nov 16 Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections
- 2022 Oct 26 Importance of TGFβ in Cancer and Nematode Infection and Their Interaction-Opinion -- Full text | PDF
- 2022 May 23 Parasite and Cancer Relationship
- 2019 Dec The Cancer Hygiene Hypothesis: From Theory to Therapeutic Helminths (book chapter)
- 2019 Sep 25 Employing Parasite Against Cancer: A Lesson From the Canine Tapeworm Echinococcus Granulocus
- 2018 Nov 26 Anti-tumor effect induced by helminth infection (Chinese)
- 2018 Sep 28 Parasites as negative regulators of cancer -- Full text | PDF
- 2017 Apr 12 Infections and cancer: the "fifty shades of immunity" hypothesis -- Full text | PDF
- 2011 Feb 23 Infection, immunoregulation, and cancer
See also
- 2023 Feb 28 Gut Microbiota Dysbiosis: The Impact on Carcinogenic Processes and the Influence of Helminths
- 2022 Oct Cancer immunosurveillance by ILC2s
- 2020 Nov 20 Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer? -- Full text | PDF
- 2019 Dec 3 ILC2s: New Actors in Tumor Immunity
- 2017 Nov 13 Eosinophils: The unsung heroes in cancer? -- Full text | PDF